This week’s media coverage of over-the-counter CBD has caused a surge in enquiries that healthcare professionals are struggling to cope with. Martin Lane investigates.

Hyped-up press coverage about the availability of over-the-counter CBD has left pharmacists and GPs dealing with an unprecedented wave of disappointed customers, according to an investigation by Cannabiz.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Join the Conversation

1 Comment

  1. This is a very well-articulated piece. As lead admin of Australia’s largest community focused on CBD products (CBD Reviews Australia), I can confirm that we’ve been inundated with posts about the news of Schedule 3 CBD. A lot of people are under the false impression that it is available now and some are under the impression that black market products are now legal.

    The media and government’s handling of this situation has been less than stellar. It’s just caused more problems and work.

    I’ve already seen a number of black market sellers take advantage of this news and claim their product is now approved. This is downright dangerous and misleading.

    How does the industry reign this in and stop those in need from potentially being harmed by misrepresented news?